A Study to Explore the Effect of Acid-reducing Agents
Clinical trial NCT04935112 · COMPLETED
Trial details
- NCT number
- NCT04935112
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2021-08-12
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.